Advances in Computational Techniques to Study GPCR-Ligand Recognition

Trends in Pharmacological Sciences

Volumn 36, Issue 12, 2015, Pages 878-890

  Ciancetta, Antonella ^a   Sabbadin, Davide ^a   Federico, Stephanie ^b   Spalluto, Giampiero ^b   Moro, Stefano ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF TRIESTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE RECEPTOR; G PROTEIN COUPLED RECEPTOR; LIGAND;

ACCURACY; ALGORITHM; BINDING AFFINITY; BINDING SITE; CALCULATION; CELL MEMBRANE; DRUG DESIGN; HYDROPHOBICITY; LIGAND BINDING; MATHEMATICAL ANALYSIS; MOLECULAR DYNAMICS; PRIORITY JOURNAL; PROTEIN INTERACTION; RECEPTOR BINDING; REVIEW; SEQUENCE ALIGNMENT; SIMULATION; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS; AGONISTS; AMINO ACID SEQUENCE; ANTAGONISTS AND INHIBITORS; CHEMISTRY; HUMAN; METABOLISM; MOLECULAR DOCKING; MOLECULAR GENETICS; MOLECULARLY TARGETED THERAPY; PROTEIN TERTIARY STRUCTURE;

AMINO ACID SEQUENCE; DRUG DESIGN; HUMANS; LIGANDS; MOLECULAR DOCKING SIMULATION; MOLECULAR DYNAMICS SIMULATION; MOLECULAR SEQUENCE DATA; MOLECULAR TARGETED THERAPY; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, G-PROTEIN-COUPLED;

EID: 84949520925     PISSN: 01656147     EISSN: 18733735     Source Type: Journal    
DOI: 10.1016/j.tips.2015.08.006     Document Type: Review

References (80)

1. R.W. Alexander, and et al. Identification of cardiac β-adrenergic receptors by (minus) [3H]alprenolol binding Proc. Natl. Acad. Sci. U.S.A. 72 1975 1564 1568
2. R.A.F. Dixon, and et al. Cloning of the gene and cDNA for mammalian β-adrenergic receptor and homology with rhodopsin Nature 321 1986 75 79
3. V. Cherezov, and et al. High-resolution crystal structure of an engineered human 2-adrenergic G protein-coupled receptor Science 318 2007 1258 1265
4. K.L. Pierce, and et al. Seven-transmembrane receptors Nat. Rev. Mol. Cell Biol. 3 2002 639 650
5. K. Kristiansen Molecular mechanisms of ligand binding, signaling, and regulation within the superfamily of G-protein-coupled receptors: molecular modeling and mutagenesis approaches to receptor structure and function Pharmacol. Ther. 103 2004 21 80
6. A.K. Shukla, and et al. Emerging structural insights into biased GPCR signaling Trends Biochem. Sci. 39 2014 594 602
7. J.L. Moreno, and et al. G protein-coupled receptor heterocomplexes in neuropsychiatric disorders Prog. Mol. Biol. Transl. Sci. 117 2013 187 205
8. M. O'Hayre, and et al. Novel insights into G protein and G protein-coupled receptor signaling in cancer Curr. Opin. Cell Biol. 27 2014 126 135
9. A. Sodhi, and et al. Viral hijacking of G-protein-coupled-receptor signalling networks Nat. Rev. Mol. Cell Biol. 5 2004 998 1012
10. P.J. Conn, and et al. Opportunities and challenges in the discovery of allosteric modulators of GPCRs for treating CNS disorders Nat. Rev. Drug Discov. 13 2014 692 708
11. K. Lundstrom Latest development in drug discovery on G protein-coupled receptors Curr. Protein Pept. Sci. 7 2006 465 470
12. R. Fredriksson The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints Mol. Pharmacol. 63 2003 1256 1272
13. D. Milić, and D.B. Veprintsev Large-scale production and protein engineering of G protein-coupled receptors for structural studies Front. Pharmacol. 6 2015 66
14. R.C. Stevens, and et al. The GPCR Network: a large-scale collaboration to determine human GPCR structure and function Nat. Rev. Drug Discov. 12 2012 25 34
15. E. Chun, and et al. Fusion partner toolchest for the stabilization and crystallization of G protein-coupled receptors Structure 20 2012 967 976
16. T. Hino, and et al. G-protein-coupled receptor inactivation by an allosteric inverse-agonist antibody Nature 482 2012 237 240
17. T. Warne, and et al. Structure of a β1-adrenergic G-protein-coupled receptor Nature 454 2008 486 491
18. J. Shonberg, and et al. GPCR crystal structures: medicinal chemistry in the pocket Bioorg. Med. Chem. 23 2015 3880 3906
19. K.A. Jacobson, and S. Costanzi New insights for drug design from the X-ray crystallographic structures of G-protein-coupled receptors Mol. Pharmacol. 82 2012 361 371
20. C.S. Tautermann GPCR structures in drug design, emerging opportunities with new structures Bioorg. Med. Chem. Lett. 24 2014 4073 4079
21. J.A. Salon, and et al. The significance of G protein-coupled receptor crystallography for drug discovery Pharmacol. Rev. 63 2011 901 937
22. G.D. Guerrero, and et al. A performance/cost evaluation for a GPU-based drug discovery application on volunteer computing Biomed. Res. Int. 2014 2014 1 8
23. I. Buch, and et al. High-throughput all-atom molecular dynamics simulations using distributed computing J. Chem. Inf. Model. 50 2010 397 403
24. J.A. Anderson, and et al. General purpose molecular dynamics simulations fully implemented on graphics processing units J. Comput. Phys. 227 2008 5342 5359
25. T. Mashimo, and et al. Molecular dynamics simulations accelerated by GPU for biological macromolecules with a non-Ewald scheme for electrostatic interactions J. Chem. Theory Comput. 9 2013 5599 5609
26. R.O. Dror, and et al. Pathway and mechanism of drug binding to G-protein-coupled receptors Proc. Natl. Acad. Sci. U.S.A. 108 2011 13118 13123
27. B. Selvam, and et al. Comparison of dynamics of extracellular accesses to the β1 and β2 adrenoceptors binding sites uncovers the potential of kinetic basis of antagonist selectivity: selectivity at the adrenoceptors Chem. Biol. Drug Des. 80 2012 215 226
28. K.J. Kohlhoff, and et al. Cloud-based simulations on Google Exacycle reveal ligand modulation of GPCR activation pathways Nat. Chem. 6 2013 15 21
29. 3 adenosine receptor antagonists as potential therapeutic agents Methods Enzymol. 485 2010 225 244
30. V. Katritch, and et al. Diversity and modularity of G protein-coupled receptor structures Trends Pharmacol. Sci. 33 2012 17 27
31. J. Simms, and et al. Homology modeling of GPCRs W.R. Leifert, G Protein-Coupled Receptors in Drug Discovery Vol. 552 2009 Humana Press 97 113
32. F. Horn GPCRDB information system for G protein-coupled receptors Nucleic Acids Res. 31 2003 294 297
33. N. Kowalsman, and M.Y. Niv GPCR & Company: databases and servers for GPCRs and interacting partners M. Filizola, G Protein-Coupled Receptors - Modeling and Simulation Vol. 796 2014 Springer 185 204
34. D. Rodríguez, and et al. Molecular modelling of G protein-coupled receptors through the web Mol. Inform. 31 2012 334 341
35. M. Floris, and et al. Adenosiland: walking through adenosine receptors landscape Eur. J. Med. Chem. 58 2012 248 257
36. V. Isberg, and et al. GPCRDB: an information system for G protein-coupled receptors Nucleic Acids Res. 42 2014 D422 D425
37. M. Floris, and et al. Implementing the "Best Template Searching" tool into Adenosiland platform Silico Pharmacol. 1 2013 25
38. H. Gutiérrez-de-Terán, and et al. Characterization of the dynamic events of GPCRs by automated computational simulations Biochem. Soc. Trans. 41 2013 205 212
39. M.D. Kelly, and R.L. Mancera Expanded interaction fingerprint method for analyzing ligand binding modes in docking and structure-based drug design J. Chem. Inf. Model. 44 2004 1942 1951
40. R.T. Kroemer, and et al. Assessment of docking poses: interactions-based accuracy classification (IBAC) versus crystal structure deviations J. Chem. Inf. Model. 44 2004 871 881
41. G. Marcou, and D. Rognan Optimizing fragment and scaffold docking by use of molecular interaction fingerprints J. Chem. Inf. Model. 47 2007 195 207
42. A.J. Kooistra, and et al. From heptahelical bundle to hits from the haystack Methods Enzymol. 522 2013 279 336
43. A.J. Kooistra, and et al. From three-dimensional GPCR structure to rational ligand discovery M. Filizola, G Protein-Coupled Receptors - Modeling and Simulation Vol. 796 2014 Springer 129 157
44. D.R. Houston, and M.D. Walkinshaw Consensus docking: improving the reliability of docking in a virtual screening context J. Chem. Inf. Model. 53 2013 384 390
45. 2A receptor as a case study J. Chem. Inf. Model. 54 2014 2243 2254
46. A. Cuzzolin, and et al. DockBench: an integrated informatic platform bridging the gap between the robust validation of docking protocols and virtual screening simulations Molecules 20 2015 9977 9993
47. Z. Deng, and et al. Structural interaction fingerprint (SIFt): a novel method for analyzing three-dimensional protein-ligand binding interactions J. Med. Chem. 47 2004 337 344
48. C. Da, and D. Kireev Structural protein-ligand interaction fingerprints (SPLIF) for structure-based virtual screening: method and benchmark study J. Chem. Inf. Model. 54 2014 2555 2561
49. M. Michino, and et al. Community-wide assessment of GPCR structure modelling and ligand docking: GPCR Dock 2008 Nat. Rev. Drug Discov. 8 2009 455 463
50. I. Kufareva, and et al. Status of GPCR modeling and docking as reflected by community-wide GPCR Dock 2010 assessment Structure 19 2011 1108 1126
51. I. Kufareva, and et al. Advances in GPCR modeling evaluated by the GPCR Dock 2013 assessment: meeting new challenges Structure 22 2014 1120 1139
52. T. Beuming, and W. Sherman Current assessment of docking into GPCR crystal structures and homology models: successes, challenges, and guidelines J. Chem. Inf. Model. 52 2012 3263 3277
53. G.L. Warren, and et al. A critical assessment of docking programs and scoring functions J. Med. Chem. 49 2006 5912 5931
54. J.D. Durrant, and J.A. McCammon Molecular dynamics simulations and drug discovery BMC Biol. 9 2011 71
55. 2A adenosine receptor as a key study J. Chem. Inf. Model. 54 2014 169 183
56. 3 adenosine receptor antagonists J. Med. Chem. 55 2012 9654 9668
57. Y. Lu, and et al. Analysis of ligand-bound water molecules in high-resolution crystal structures of protein-ligand complexes J. Chem. Inf. Model. 47 2007 668 675
58. P.W. Snyder, and et al. Mechanism of the hydrophobic effect in the biomolecular recognition of arylsulfonamides by carbonic anhydrase Proc. Natl. Acad. Sci. U.S.A. 108 2011 17889 17894
59. 2A antagonists as a case study J. Chem. Inf. Model. 53 2013 1700 1713
60. S. Yuan, and et al. Activation of G-protein-coupled receptors correlates with the formation of a continuous internal water pathway Nat. Commun. 5 2014 4733
61. T. Beuming, and et al. Thermodynamic analysis of water molecules at the surface of proteins and applications to binding site prediction and characterization Proteins 80 2012 871 883
62. L. Wang, and et al. Ligand binding to protein-binding pockets with wet and dry regions Proc. Natl. Acad. Sci. U.S.A. 108 2011 1326 1330
63. J.S. Mason, and et al. High end GPCR design: crafted ligand design and druggability analysis using protein structure, lipophilic hotspots and explicit water networks Silico Pharmacol. 1 2013 23
64. 2A receptor Med. Chem. Commun. 5 2014 571
65. 2A adenosine receptor as a key study J. Chem. Inf. Model. 54 2014 2846 2855
66. I. Buch, and et al. Complete reconstruction of an enzyme-inhibitor binding process by molecular dynamics simulations Proc. Natl. Acad. Sci. U.S.A. 108 2011 10184 10189
67. R.O. Dror, and et al. Structural basis for modulation of a G-protein-coupled receptor by allosteric drugs Nature 503 2013 295 299
68. D.E. Shaw, and et al. Millisecond-scale molecular dynamics simulations on Anton Proceedings of the Conference on High Performance Computing Networking, Storage and Analysis Association for Computing Machinery 2009 1
69. J.M. Johnston, and M. Filizola Beyond standard molecular dynamics: investigating the molecular mechanisms of G protein-coupled receptors with enhanced molecular dynamics methods M. Filizola, G Protein-Coupled Receptors - Modeling and Simulation Vol. 796 2014 Springer 95 125
70. D. Sabbadin, and S. Moro Supervised molecular dynamics (SuMD) as a helpful tool to depict GPCR-ligand recognition pathway in a nanosecond time scale J. Chem. Inf. Model. 54 2014 372 376
71. 2A adenosine receptor of the endogenous agonist adenosine using supervised molecular dynamics simulations Med. Chem. Commun. 2015 10.1039/C5MD00016E Published online April 20, 2015
72. G. Deganutti, and et al. Understanding allosteric interactions in G protein-coupled receptors using supervised molecular dynamics: a prototype study analysing the human A3 adenosine receptor positive allosteric modulator LUF6000 Bioorg. Med. Chem. 23 2015 4065 4071
73. M.A. Lomize, and et al. OPM: orientations of proteins in membranes database Bioinformatics 22 2006 623 625
74. E.L. Wu, and et al. CHARMM-GUI Membrane Builder toward realistic biological membrane simulations J. Comput. Chem. 35 2014 1997 2004
75. T.H. Schmidt, and C. Kandt LAMBADA and InflateGRO2: efficient membrane alignment and insertion of membrane proteins for molecular dynamics simulations J. Chem. Inf. Model. 52 2012 2657 2669
76. T. Nugent, and D.T. Jones Membrane protein orientation and refinement using a knowledge-based statistical potential BMC Bioinformatics 14 2013 276
77. R. Staritzbichler, and et al. GRIFFIN: a versatile methodology for optimization of protein-lipid interfaces for membrane protein simulations J. Chem. Theory Comput. 7 2011 1167 1176
78. M.G. Wolf, and et al. g-membed: efficient insertion of a membrane protein into an equilibrated lipid bilayer with minimal perturbation J. Comput. Chem. 31 2010 2169 2174
79. M. Javanainen Universal method for embedding proteins into complex lipid bilayers for molecular dynamics simulations J. Chem. Theory Comput. 10 2014 2577 2582
80. P.J. Stansfeld, and et al. MemProtMD: automated insertion of membrane protein structures into explicit lipid membranes Structure 23 2015 1350 1361